Lexicon Pharmaceuticals (LXRX) Total Debt Growth (1y) (2011 - 2026)
Lexicon Pharmaceuticals (LXRX) Total Debt Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - | 103.99% |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn | 3.84% |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn | 0.07% |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - | - |
| 10 | Lexicon Pharmaceuticals | 942.57 Mn | 771.91 Mn | 20.99 Mn | -50.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.66% |
| Dec 31, 2025 | -46.16% |
| Sep 30, 2025 | -43.43% |
| Jun 30, 2025 | -43.62% |
| Mar 31, 2025 | 0.80% |
| Dec 31, 2024 | 0.79% |
| Sep 30, 2024 | 0.63% |
| Jun 30, 2024 | 0.71% |
| Mar 31, 2024 | 104.71% |
| Dec 31, 2023 | 104.84% |
| Sep 30, 2023 | 317.36% |
| Jun 30, 2023 | 318.64% |
| Mar 31, 2023 | 107.86% |
| Sep 30, 2022 | 103.40% |
| Jun 30, 2022 | 102.14% |
| Mar 31, 2022 | 101.35% |
| Sep 30, 2021 | -42.46% |
| Jun 30, 2021 | -95.24% |
| Mar 31, 2021 | -95.25% |
| Dec 31, 2020 | -95.25% |